Wave Life Sciences Ltd. (WVE) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Wave Life Sciences Ltd..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.237 Good morning and welcome to the Wave Life Sciences first quarter 2025 earnings conference 00:00:05.237 -- 00:00:06.738 call. 00:00:06.738 -- 00:00:10.002 At this time, all participants are in the listen-only mode. 00:00:10.002 -- 00:00:14.166 As a reminder, this call is being recorded and webcasted. 00:00:14.166 -- 00:00:17.370 After today's presentation, there'll be an opportunity to ask questions. 00:00:17.370 -- 00:00:21.594 To ask a question, you may press star and one on your touchtone telephone. 00:00:21.594 -- 00:00:25.058 To withdraw your question, you may press star and two. 00:00:25.058 -- 00:00:30.149 I now turn the call over to Kate Roche, Vice President, Investor Relations and Corporate 00:00:30.149 -- 00:00:33.153 Affairs. Please go ahead. 00:00:33.153 -- 00:00:35.937 Thank you, Operator, and good morning to everyone on the call. 00:00:35.937 -- 00:00:40.263 Earlier this morning, we issued a press release outlining our first quarter 2025 earnings 00:00:40.263 -- 00:00:45.149 update, including progress updates for obesity and AATB clinical trials. 00:00:45.149 -- 00:00:47.232 Joining me today with prepared remarks are Dr. 00:00:47.232 -- 00:00:50.616 Paul Volno, President and Chief Executive Officer, Dr. 00:00:50.616 -- 00:00:55.718 Eric Engelson, Chief Scientific Officer, and Kyle Moran, Chief Financial Officer. 00:00:55.718 -- 00:00:59.904 The press release issued this morning is available on the investor section of our website, 00:00:59.904 -- 00:01:01.904 www.wavelifesciences.com. 00:01:03.390 -- 00:01:06.755 Before we begin, I would like to remind you that discussions during this conference call 00:01:06.755 -- 00:01:10.600 will include forward-looking statements. These statements are subject to several risks 00:0...